DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.verified

DMAC

Price:

$4.7

Market Cap:

$200.97M

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutic...[Read more]

Industry

Biotechnology

IPO Date

2012-08-03

Stock Exchange

NASDAQ

Ticker

DMAC

The Dividend Yield as of November 2024 (TTM) for DiaMedica Therapeutics Inc. (DMAC) is 0%

According to DiaMedica Therapeutics Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

DiaMedica Therapeutics Inc. (DMAC) Historical Dividend Yield (quarterly & annually)

How has DMAC Dividend Yield performed in the past?

The mean historical Dividend Yield of DiaMedica Therapeutics Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), DMAC's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

DiaMedica Therapeutics Inc. (DMAC) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of DiaMedica Therapeutics Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

DiaMedica Therapeutics Inc. (DMAC) Average Dividend Yield

How has DMAC Dividend Yield performed in the past?

The current Dividend Yield of DiaMedica Therapeutics Inc. (DMAC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

DiaMedica Therapeutics Inc. (DMAC) Dividend Yield vs. Peers

How is DMAC’s Dividend Yield compared to its peers?

DiaMedica Therapeutics Inc.’s Dividend Yield is less than Milestone Pharmaceuticals Inc. (0%), less than Seres Therapeutics, Inc. (0%), less than Inhibikase Therapeutics, Inc. (0%), less than Oncolytics Biotech Inc. (0%), less than scPharmaceuticals Inc. (0%), less than aTyr Pharma, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Centessa Pharmaceuticals plc (0%), less than Iovance Biotherapeutics, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Galera Therapeutics, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than HOOKIPA Pharma Inc. (0%), less than null (0%),

Build a custom stock screener for DiaMedica Therapeutics Inc. (DMAC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DiaMedica Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DiaMedica Therapeutics Inc. (DMAC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DiaMedica Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is DiaMedica Therapeutics Inc.'s Dividend Yield?

How is the Dividend Yield calculated for DiaMedica Therapeutics Inc. (DMAC)?

What is the highest Dividend Yield for DiaMedica Therapeutics Inc. (DMAC)?

What is the 3-year average Dividend Yield for DiaMedica Therapeutics Inc. (DMAC)?

What is the 5-year average Dividend Yield for DiaMedica Therapeutics Inc. (DMAC)?

How does the current Dividend Yield for DiaMedica Therapeutics Inc. (DMAC) compare to its historical average?